Insider Stock Trading History of Pakianathan Deepika


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Pakianathan Deepika since year 2005. The trader's CIK number is 1270734. At the time of this reporting, Pakianathan Deepika is the Director of Karyopharm Therapeutics Inc. . (stock ticker symbol KPTI). See this page for all insider trading activities at Karyopharm Therapeutics Inc. .

Note that in the past PAKIANATHAN DEEPIKA also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Pakianathan Deepika since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-01-12 KPTI Karyopharm Therapeutics Inc. Buy 45,454 33.00 1,499,982
2014-10-07 CALA Calithera Biosciences, Inc. Buy 500,000 10.00 5,000,000
2014-10-07 CALA Calithera Biosciences, Inc. Buy 500,000 10.00 5,000,000
2014-08-19 OMED Oncomed Pharmaceuticals Inc Buy 12,541 18.89 236,886
2014-08-20 OMED Oncomed Pharmaceuticals Inc Buy 46,059 19.00 874,982
2014-08-21 OMED Oncomed Pharmaceuticals Inc Buy 21,603 18.98 409,981
2014-05-21 KPTI Karyopharm Therapeutics Inc. Buy 92,650 26.19 2,426,874
2014-05-22 KPTI Karyopharm Therapeutics Inc. Buy 20,000 26.09 521,800
2014-05-23 KPTI Karyopharm Therapeutics Inc. Buy 1,769 26.45 46,784
2014-05-13 ALDR Alder Biopharmaceuticals Inc Buy 350,000 10.00 3,500,000
2014-04-22 TRIV Trivascular Technologies, Inc. Buy 833,333 12.00 9,999,996
2013-11-12 KPTI Karyopharm Therapeutics Inc. Buy 312,500 16.00 5,000,000
2013-07-23 OMED Oncomed Pharmaceuticals Inc Buy 382,353 17.00 6,500,001
2006-03-08 ALXA Alexza Pharmaceuticals Inc. Buy 1,000 8.00 8,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pakianathan Deepika (Director of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.